News
AOP Orphan hosted an Experts Press Conference at DGHO in Berlin
7. 10. 2019AOP Orphan hosted Industry Symposium at DGHO in Berlin
7. 10. 2019AOP Orphan Pharmaceuticals AG, AOP Orphan IP AG and orphanix GmbH join forces to develop RetinolX to prevent bronchopulmonary dysplasia
13. 5. 2019
Meet Us Globally
- 23Mar.
Bio-Europe Spring 2020
PARIS, FRANCE - 4Apr.
11th European Narcolepsy Day
BERLIN, GERMANy - 6May.
Outsourcing in Clinical Trials
PARIS, FRANCE
Meet Us in United Kingdom
- 6Mar.
Chronic Myeloid Leukaemia Myeloproliferative Neoplsam Annual Nurse Meeting
LONDON, UK
From the Concept to the Drug
AOP Orphan team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
Partnering
Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.